核治療薬の世界市場レポート 2024年

核治療市場規模は、今後数年で急成長が見込まれます。2028年の年間平均成長率（CAGR）は14.8％で、33億6,000万米ドルに成長します。予測期間中に予想される成長は、個別化医療へのシフト、医療インフラの改善需要の増加、高齢者の増加、画像診断手技の増加、個別化医療提供への注目の高まりなど、いくつかの要因に起因しています。この期間に予想される主要動向には、ナノ粒子ベースの送達システムの開発、放射性核種治療の進展、ハイブリッド画像システム、放射性医薬品製造の進歩とアルファ線放出放射性医薬品の開発、機械学習と人工知能の統合などがあります。

がんの有病率の上昇が核治療市場の成長を牽引すると予想されます。異常細胞の制御不能な増殖と拡散を特徴とするがんは、発見と診断の改善、ライフスタイルの選択、環境暴露、遺伝的素因などの要因により、より蔓延しつつあります。核治療は、腫瘍の縮小、症状の緩和、患者のQOLの向上に役立つ標的を絞った効果的な治療法を提供することで、がん治療において重要な役割を果たしています。例えば、2024年2月、スイスに本部を置く国連機関である世界保健機関（WHO）は、2050年までに新たに診断されるがん患者は3,500万人を超え、2022年の推定2,000万人から77％増加すると予測しました。その結果、がん罹患率の増加が核治療市場の拡大に拍車をかけています。

核治療市場の主要企業は、競合を強化するために戦略的パートナーシップを結ぶことが増えています。こうした提携は、研究開発能力を強化し、新しい治療法の商業化を加速し、共有するリソースや専門知識を活用して革新的な治療法へのアクセスを改善する上で極めて重要です。例えば、2022年7月、ドイツを拠点とするソフトウェア会社DeepCは、核医療診断の進歩のため、米国を拠点とするAIソリューションプロバイダーであるPAIREと提携しました。この提携により、PET/CTスキャンの解釈を強化するDeepCのdeepcOSプラットフォームにPAIREのAIソリューションであるPionusを統合することで、核医療診断の精度と効率の向上を目指します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界の市場規模と成長

• 世界の核治療市場：促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の核治療市場の実績：規模と成長、2018～2023年
• 世界の核治療市場の予測：規模と成長、2023～2028年、2033年

第6章 市場セグメンテーション

• 世界の核治療市場：タイプ別、実績と予測、2018～2023年、2023～2028年、2033年
• ラジウム223
• ルテチウム177
• ヨウ素131
• その他
• 世界の核治療市場：流通チャネル別、実績と予測、2018～2023年、2023～2028年、2033年
• 病院
• 外来手術センター（ASC）
• がん研究機関
• 世界の核治療市場：用途別、実績と予測、2018～2023年、2023～2028年、2033年
• 甲状腺
• 骨転移
• リンパ腫
• その他

第7章 地域別・国別分析

• 世界の核治療市場：地域別、実績と予測、2018～2023年、2023～2028年、2033年
• 世界の核治療市場：国別、実績と予測、2018～2023年、2023～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 核治療市場：競合情勢
• 核治療市場：企業プロファイル
  • Bayer AG
  • Novartis International AG
  • Siemens Healthineers AG
  • Ipsen S.A.
  • Jubilant DraxImage Inc.

第31章 その他の大手企業と革新的企業

• Mallinckrodt Pharmaceuticals PLC
• The Bracco Group
• Lantheus Medical Imaging Inc.
• Piramal Group
• Curium Pharmaceuticals
• Yantai Dongcheng Pharmaceutical Group Co. Ltd.
• Eckert & Ziegler
• Telix Pharmaceuticals Limited
• International Isotopes inc.
• Orano SA
• Q BioMed Inc.
• Molecular Targeting Technologies Inc
• Medi-Radiopharma Co. Ltd.
• Actinium Pharmaceuticals
• Fusion Pharmaceuticals

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の展望と潜在的な分析

第36章 付録

Therapeutic nuclear drugs are medications that use radioactive materials to target and treat diseases, primarily cancer. These drugs employ targeted radiopharmaceuticals that bind to cancer cells and deliver a therapeutic dose of radiation directly to them, aiming to destroy the cancerous cells while minimizing damage to surrounding healthy tissue.

The main types of therapeutic nuclear drugs include radium-223, lutetium-177, iodine-131, and others. Radium-223, for example, is used mainly to treat prostate cancer that has metastasized to the bones. These drugs are distributed through various channels such as hospitals, ambulatory surgical centers, and cancer research institutes, and are utilized in applications like treating thyroid cancer, bone metastases, lymphoma, and other conditions.

The therapeutic nuclear drugs market research report is one of a series of new reports from The Business Research Company that provides therapeutic nuclear drugs market statistics, including the therapeutic nuclear drugs industry global market size, regional shares, competitors with a therapeutic nuclear drugs market share, detailed therapeutic nuclear drugs market segments, market trends, and opportunities, and any further data you may need to thrive in the therapeutic nuclear drugs industry. This therapeutic nuclear drug research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The therapeutic nuclear drug market size has grown rapidly in recent years. It will grow from $1.69 billion in 2023 to $1.94 billion in 2024 at a compound annual growth rate (CAGR) of 14.5%. The historical growth can be attributed to several factors, including increased regulatory approvals, greater use of patient-specific information, advancements in dosimetry techniques, rising awareness of nuclear medicines, and higher investments in research and development activities.

The therapeutic nuclear drug market size is expected to see rapid growth in the next few years. It will grow to $3.36 billion in 2028 at a compound annual growth rate (CAGR) of 14.8%. The anticipated growth during the forecast period can be attributed to several factors, including a shift towards personalized medicine, increased demand for improvements in healthcare infrastructure, a growing geriatric population, a rise in diagnostic imaging procedures, and the increasing focus on personalized care delivery. Key trends expected during this period include the development of nanoparticle-based delivery systems, advancements in radionuclide therapy, hybrid imaging systems, progress in radiopharmaceutical manufacturing and the development of alpha-emitting radiopharmaceuticals, and the integration of machine learning and artificial intelligence.

The rising prevalence of cancer is expected to drive the growth of the therapeutic nuclear drug market. Cancer, characterized by the uncontrolled growth and spread of abnormal cells, is becoming more prevalent due to factors such as improved detection and diagnosis, lifestyle choices, environmental exposures, and genetic predisposition. Therapeutic nuclear drugs play a crucial role in cancer treatment by offering targeted, effective therapies that help reduce tumor size, alleviate symptoms, and improve patients' quality of life. For example, in February 2024, the World Health Organization (WHO), a Switzerland-based UN agency, projected that over 35 million new cancer cases will be diagnosed by 2050, marking a 77% increase from the estimated 20 million cases in 2022. As a result, the growing prevalence of cancer is fueling the expansion of the therapeutic nuclear drug market.

Major companies in the therapeutic nuclear drug market are increasingly forming strategic partnerships to strengthen their competitive position. These collaborations are crucial for enhancing research and development capabilities, speeding up the commercialization of new therapies, and improving access to innovative treatments by leveraging shared resources and expertise. For example, in July 2022, DeepC, a Germany-based software company, partnered with PAIRE, a U.S.-based AI solutions provider, to advance nuclear medicine diagnostics. Through this partnership, they aim to improve the precision and efficiency of nuclear medicine diagnostics by integrating PAIRE's AI solution, Pionus, into DeepC's deepcOS platform, which enhances the interpretation of PET/CT scans.

In May 2024, Telix Pharmaceuticals Limited, an Australian biotechnology company, acquired QSAM Biosciences for an undisclosed amount. This acquisition aims to bolster Telix's therapeutic pipeline with the investigational drug Samarium-153-DOTMP, which targets bone metastases and osteosarcoma. QSAM Biosciences, a US-based biotech firm, specializes in developing next-generation nuclear therapeutic medicines.

Major companies operating in the therapeutic nuclear drug market are Bayer AG, Novartis International AG, Siemens Healthineers AG, Ipsen S.A., Jubilant DraxImage Inc., Mallinckrodt Pharmaceuticals PLC, The Bracco Group, Lantheus Medical Imaging Inc., Piramal Group, Curium Pharmaceuticals, Yantai Dongcheng Pharmaceutical Group Co. Ltd., Eckert & Ziegler, Telix Pharmaceuticals Limited, International Isotopes inc., Orano SA, Q BioMed Inc., Molecular Targeting Technologies Inc, Medi-Radiopharma Co. Ltd., Actinium Pharmaceuticals, Fusion Pharmaceuticals

North America was the largest region in the therapeutic nuclear drug market in 2023. The regions covered in the therapeutic nuclear drug market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the therapeutic nuclear drug market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The therapeutic nuclear drug market consists of sales of yttrium-90, actinium-225, bismuth-213, therapeutic iodine-123, and copper-67. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Therapeutic Nuclear Drug Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on therapeutic nuclear drug market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for therapeutic nuclear drug ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The therapeutic nuclear drug market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Radium-223; Lutetium-177; Iodine-131; Other Types
• 2) By Distribution Channel: Hospitals; Ambulatory Surgical Centers (ASCs); Cancer Research Institutes
• 3) By Application: Thyroid; Bone Metastasis; Lymphoma; Other Applications
• Companies Mentioned: Bayer AG; Novartis International AG; Siemens Healthineers AG; Ipsen S.A.; Jubilant DraxImage Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Therapeutic Nuclear Drug Market Characteristics

3. Therapeutic Nuclear Drug Market Trends And Strategies

4. Therapeutic Nuclear Drug Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Therapeutic Nuclear Drug Market Size and Growth

• 5.1. Global Therapeutic Nuclear Drug Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Therapeutic Nuclear Drug Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Therapeutic Nuclear Drug Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Therapeutic Nuclear Drug Market Segmentation

• 6.1. Global Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Radium-223
• Lutetium-177
• Iodine-131
• Other Types
• 6.2. Global Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Cancer Research Institutes
• 6.3. Global Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Thyroid
• Bone Metastasis
• Lymphoma
• Other Applications

7. Therapeutic Nuclear Drug Market Regional And Country Analysis

• 7.1. Global Therapeutic Nuclear Drug Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Therapeutic Nuclear Drug Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Therapeutic Nuclear Drug Market

• 8.1. Asia-Pacific Therapeutic Nuclear Drug Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Therapeutic Nuclear Drug Market

• 9.1. China Therapeutic Nuclear Drug Market Overview
• 9.2. China Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Therapeutic Nuclear Drug Market

• 10.1. India Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Therapeutic Nuclear Drug Market

• 11.1. Japan Therapeutic Nuclear Drug Market Overview
• 11.2. Japan Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Therapeutic Nuclear Drug Market

• 12.1. Australia Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Therapeutic Nuclear Drug Market

• 13.1. Indonesia Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Therapeutic Nuclear Drug Market

• 14.1. South Korea Therapeutic Nuclear Drug Market Overview
• 14.2. South Korea Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Therapeutic Nuclear Drug Market

• 15.1. Western Europe Therapeutic Nuclear Drug Market Overview
• 15.2. Western Europe Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Therapeutic Nuclear Drug Market

• 16.1. UK Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Therapeutic Nuclear Drug Market

• 17.1. Germany Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Therapeutic Nuclear Drug Market

• 18.1. France Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Therapeutic Nuclear Drug Market

• 19.1. Italy Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Therapeutic Nuclear Drug Market

• 20.1. Spain Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Therapeutic Nuclear Drug Market

• 21.1. Eastern Europe Therapeutic Nuclear Drug Market Overview
• 21.2. Eastern Europe Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Therapeutic Nuclear Drug Market

• 22.1. Russia Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Therapeutic Nuclear Drug Market

• 23.1. North America Therapeutic Nuclear Drug Market Overview
• 23.2. North America Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Therapeutic Nuclear Drug Market

• 24.1. USA Therapeutic Nuclear Drug Market Overview
• 24.2. USA Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Therapeutic Nuclear Drug Market

• 25.1. Canada Therapeutic Nuclear Drug Market Overview
• 25.2. Canada Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Therapeutic Nuclear Drug Market

• 26.1. South America Therapeutic Nuclear Drug Market Overview
• 26.2. South America Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Therapeutic Nuclear Drug Market

• 27.1. Brazil Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Therapeutic Nuclear Drug Market

• 28.1. Middle East Therapeutic Nuclear Drug Market Overview
• 28.2. Middle East Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Therapeutic Nuclear Drug Market

• 29.1. Africa Therapeutic Nuclear Drug Market Overview
• 29.2. Africa Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Therapeutic Nuclear Drug Market Competitive Landscape And Company Profiles

• 30.1. Therapeutic Nuclear Drug Market Competitive Landscape
• 30.2. Therapeutic Nuclear Drug Market Company Profiles
  • 30.2.1. Bayer AG
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Novartis International AG
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Siemens Healthineers AG
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Ipsen S.A.
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Jubilant DraxImage Inc.
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Therapeutic Nuclear Drug Market Other Major And Innovative Companies

• 31.1. Mallinckrodt Pharmaceuticals PLC
• 31.2. The Bracco Group
• 31.3. Lantheus Medical Imaging Inc.
• 31.4. Piramal Group
• 31.5. Curium Pharmaceuticals
• 31.6. Yantai Dongcheng Pharmaceutical Group Co. Ltd.
• 31.7. Eckert & Ziegler
• 31.8. Telix Pharmaceuticals Limited
• 31.9. International Isotopes inc.
• 31.10. Orano SA
• 31.11. Q BioMed Inc.
• 31.12. Molecular Targeting Technologies Inc
• 31.13. Medi-Radiopharma Co. Ltd.
• 31.14. Actinium Pharmaceuticals
• 31.15. Fusion Pharmaceuticals

32. Global Therapeutic Nuclear Drug Market Competitive Benchmarking

33. Global Therapeutic Nuclear Drug Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Therapeutic Nuclear Drug Market

35. Therapeutic Nuclear Drug Market Future Outlook and Potential Analysis

• 35.1 Therapeutic Nuclear Drug Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Therapeutic Nuclear Drug Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Therapeutic Nuclear Drug Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer